SCHEMBL10017519

SCHEMBL10017519

C=C(CCC(C)C1CCC2(C)C3CCC4C(C)(C)C(OC(=O)/C=C/c5ccc(OCC)c(CO)c5)CCC45CC35CCC12C)C(C)C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.58
▸ KMT2A Q03164 1/20 0.58
▸ HSD11B1 P28845 7/20 0.42
▸ SLC10A1 Q14973 1/20 0.41
▸ RELA Q04206 1/20 0.39
▸ ACLY P53396 2/20 0.38
▸ ACACA Q13085 2/20 0.38
▸ PTPN11 Q06124 1/20 0.36
▸ HSD11B2 P80365 2/20 0.34
▸ MAPT P10636 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ GAA P10253 1/20 0.33
▸ XBP1 P17861 1/20 0.33
▸ NPSR1 Q6W5P4 1/20 0.33
▸ ELANE P08246 1/20 0.33
▸ USP2 O75604 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ CYP3A4 P08684 1/20 0.30
▸ ALOX15 P16050 1/20 0.30
▸ NR3C1 P04150 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10017449 0.94 MEN1 (0.63) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL10017525 0.91 MEN1 (0.47) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL10017520 0.90 ACLY (0.47) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL10049047 0.89 KMT2A (0.67) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL23484310 0.87 MEN1 (0.76) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL6438953 0.87 MEN1 (0.76) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL12152369 0.87 MEN1 (0.76) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL10017464 0.86 MEN1 (0.54) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL23791003 0.86 MEN1 (0.58) MEN1KMT2AHSD11B1SLC10A1RELA
SCHEMBL10017522 0.85 MEN1 (0.43) MEN1KMT2AHSD11B1SLC10A1RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9541795-B2 Liquid crystal display device and method for manufacturing the same SONY CORPORATION (JP) 2017-01-10 — — US disclosed
US-9523889-B2 Liquid crystal display unit and method of manufacturing the same SONY CORPORATION (JP) 2016-12-20 — — US disclosed
US-9507210-B2 Liquid crystal display and method of manufacturing the same SONY CORPORATION (JP) 2016-11-29 — — US disclosed
US-9470929-B2 Liquid crystal display unit and method of manufacturing the same SONY CORPORATION (JP) 2016-10-18 — — US disclosed
US-9465244-B2 Liquid crystal display SONY CORPORATION (JP) 2016-10-11 — — US disclosed
US-9366910-B2 Liquid crystal display and method of manufacturing the same SONY CORPORATION (JP) 2016-06-14 — — US disclosed
US-20160011463-A1 LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2016-01-14 — — US disclosed
US-9235084-B2 Liquid crystal display device and manufacturing method thereof SONY CORPORATION (JP) 2016-01-12 — — US disclosed
US-9146425-B2 Liquid crystal display and method of manufacturing the same SONY CORPORATION (JP) 2015-09-29 — — US disclosed
US-20150146148-A1 LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2015-05-28 — — US disclosed
US-20140071390-A1 LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF SONY CORPORATION (JP) 2014-03-13 — — US disclosed
US-20130155360-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2013-06-20 — — US disclosed
US-20130010244-A1 LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION 2013-01-10 — — US disclosed
US-20120218500-A1 LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF SONY CORPORATION (JP) 2012-08-30 — — US disclosed
US-20120212691-A1 LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF SONY CORPORATION (JP) 2012-08-23 — — US disclosed
US-20120212697-A1 LIQUID CRYSTAL DISPLAY DEVICE AND MANUFACTURING METHOD THEREOF SONY CORPORATION (JP) 2012-08-23 — — US disclosed
US-20120026440-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME SONY CORPORATION (JP) 2012-02-02 — — US disclosed
US-20110273652-A1 LIQUID CRYSTAL DISPLAY AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2011-11-10 — — US disclosed
US-20110157531-A1 LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME SONY CORPORATION (JP) 2011-06-30 — — US disclosed
US-20110134382-A1 LIQUID CRYSTAL DISPLAY ELEMENT AND LIQUID CRYSTAL DISPLAY DEVICE SONY CORPORATION (JP) 2011-06-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160011463-A1 LIQUID CRYSTAL DISPLAY UNIT AND METHOD OF MANUFACTURING THE SAME PYM1, PDCD2L, SDAD1 MEN1 2607/4885KMT2A 3545/4885HSD11B1 1773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback